PARP1 and non-small cell lung carcinoma: Furthermore, the lncRNA NSCLCAT1 inhibited cell apoptosis and accelerated NSCLC progression by inactivating the Hippo signalling pathway via inhibition of CDH1, with a decrease in the levels of Bax, cleaved caspase-3, and cleaved PARP and an increase in Bcl-2 expression [43].